10-Q Filing

PRIVIA HEALTH GROUP, INC. CIK: 1759655 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0001759655-22-000118`
Period End Date	20220630
Filing Date	20220811
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	prva-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 74 Cash Flow Statement 64 Stockholders Equity 31

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$320.58M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	107.84M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$292.19M	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	109.58M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$213.89M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	107.84M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$117.40M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	109.58M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$8.70M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$15.19M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$521.27M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$446.68M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.96M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.50M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$8.81M	USD	Point-in-time
Right-of-use asset	`OperatingLeaseRightOfUseAsset`	$9.63M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$59.74M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$59.07M	USD	Point-in-time
Goodwill	`Goodwill`	$126.94M	USD	Point-in-time
Goodwill	`Goodwill`	$127.94M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$21.82M	USD	Point-in-time
Deferred tax asset	`DeferredIncomeTaxAssetsNet`	$33.36M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$4.52M	USD	Point-in-time
Other non-current assets	`OtherAssetsNoncurrent`	$3.12M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$223.72M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$239.70M	USD	Point-in-time
Total assets	`Assets`	$744.99M	USD	Point-in-time
Total assets	`Assets`	$686.37M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$45.98M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$40.33M	USD	Point-in-time
Provider liability	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$140.71M	USD	Point-in-time
Provider liability	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$221.88M	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	$875.00K	USD	Point-in-time
Current portion of note payable	`NotesPayableCurrent`	-	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$2.89M	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$2.93M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$190.46M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$265.14M	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	-	USD	Point-in-time
Note payable, net of current portion	`LongTermNotesPayable`	$31.69M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$9.74M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$11.04M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.00M	USD	Point-in-time
Other non-current liabilities	`OtherLiabilitiesNoncurrent`	$3.00M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$45.73M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$12.74M	USD	Point-in-time
Total liabilities	`Liabilities`	$277.88M	USD	Point-in-time
Total liabilities	`Liabilities`	$236.19M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 109,582,734 and 107,837,741 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$1.08M	USD	Point-in-time
Common stock, $0.01 par value, 1,000,000,000 and 1,000,000,000 shares authorized; 109,582,734 and 107,837,741 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively	`CommonStockValue`	$1.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$633.90M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$680.15M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-208.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-236.09M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$426.87M	USD	Point-in-time
Total Privia Health Group, Inc. stockholders equity	`StockholdersEquity`	$445.15M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$21.95M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$23.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.90M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$467.11M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$744.99M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$686.37M	USD	Point-in-time

Income Statement 74 line items

Line Item	Tag	Value	Unit	Period
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$335.54M	USD	1 Quarter
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$439.36M	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$649.34M	USD	2 Qtrs
Revenue	`RevenueFromContractWithCustomerIncludingAssessedTax`	$225.76M	USD	1 Quarter
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$259.31M	USD	1 Quarter
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$501.50M	USD	2 Qtrs
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$331.05M	USD	2 Qtrs
Provider expense	`LiabilityForFuturePolicyBenefitsPeriodExpense`	$169.94M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$68.73M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$42.38M	USD	1 Quarter
Cost of platform	`CostOfPlatform`	$83.66M	USD	2 Qtrs
Cost of platform	`CostOfPlatform`	$95.69M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$4.82M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$9.48M	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$11.18M	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$14.36M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$168.66M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$182.65M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$33.11M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$69.22M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$885.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$440.00K	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.28M	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.17M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$624.64M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$418.94M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$340.79M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$666.13M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-5.25M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-16.80M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-193.19M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-185.28M	USD	2 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-663.00K	USD	1 Quarter
Interest expense	`InterestIncomeExpenseNet`	$-895.00K	USD	2 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-593.00K	USD	2 Qtrs
Interest expense	`InterestIncomeExpenseNet`	$-302.00K	USD	1 Quarter
Loss before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-185.87M	USD	2 Qtrs
Loss before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-193.49M	USD	1 Quarter
Loss before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-5.91M	USD	1 Quarter
Loss before provision for (benefit from) income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-17.69M	USD	2 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$5.47M	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-20.00M	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$11.78M	USD	2 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-18.00M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-29.47M	USD	2 Qtrs
Net loss	`ProfitLoss`	$5.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.38M	USD	1 Quarter
Net loss	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-18.09M	USD	1 Quarter
Net loss	`ProfitLoss`	$-167.87M	USD	2 Qtrs
Less: loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.48M	USD	2 Qtrs
Less: loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-951.00K	USD	1 Quarter
Less: loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-906.00K	USD	1 Quarter
Less: loss attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-733.00K	USD	2 Qtrs
Net loss attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-167.14M	USD	2 Qtrs
Net loss attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-172.53M	USD	1 Quarter
Net loss attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-27.98M	USD	2 Qtrs
Net loss attributable to Privia Health Group, Inc.	`NetIncomeLoss`	$-10.47M	USD	1 Quarter
Net loss per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-0.26	USD	2 Qtrs
Net loss per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-1.68	USD	2 Qtrs
Net loss per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-1.68	USD	1 Quarter
Net loss per share attributable to Privia Health Group, Inc. stockholders basic (in dollars per share)	`EarningsPerShareBasic`	$-0.10	USD	1 Quarter
Net loss per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.26	USD	2 Qtrs
Net loss per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.10	USD	1 Quarter
Net loss per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.68	USD	2 Qtrs
Net loss per share attributable to Privia Health Group, Inc. stockholders diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.68	USD	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	108.69M	shares	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	102.74M	shares	1 Quarter
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	99.38M	shares	2 Qtrs
Weighted average common shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	108.37M	shares	2 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	102.74M	shares	1 Quarter
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	108.69M	shares	1 Quarter
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	99.38M	shares	2 Qtrs
Weighted average common shares outstanding diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	108.37M	shares	2 Qtrs

Cash Flow Statement 64 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-29.47M	USD	2 Qtrs
Net loss	`ProfitLoss`	$5.62M	USD	1 Quarter
Net loss	`ProfitLoss`	$-11.38M	USD	1 Quarter
Net loss	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net loss	`ProfitLoss`	$-18.09M	USD	1 Quarter
Net loss	`ProfitLoss`	$-167.87M	USD	2 Qtrs
Depreciation	`Depreciation`	$564.00K	USD	2 Qtrs
Depreciation	`Depreciation`	$615.00K	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$1.67M	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$200.00K	USD	1 Quarter
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$320.00K	USD	2 Qtrs
Amortization of intangibles	`AmortizationOfIntangibleAssets`	$900.00K	USD	1 Quarter
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$77.00K	USD	2 Qtrs
Amortization of debt issuance costs	`AmortizationAdditionOfDebtIssuanceCosts`	$687.00K	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$43.35M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$202.66M	USD	2 Qtrs
Deferred tax expense	`DeferredIncomeTaxExpenseBenefit`	$11.54M	USD	2 Qtrs
Deferred tax expense	`DeferredIncomeTaxExpenseBenefit`	$-18.21M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$96.49M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$27.75M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$3.49M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$6.49M	USD	2 Qtrs
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$-2.23M	USD	2 Qtrs
Other non-current assets and right-of-use asset	`IncreaseDecreaseInOtherNoncurrentAssets`	$4.28M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$-6.55M	USD	2 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayable`	$-5.65M	USD	2 Qtrs
Provider liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$24.22M	USD	2 Qtrs
Provider liability	`IncreaseDecreasePhysicianAndPracticeLiability`	$81.17M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$10.31M	USD	2 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiability`	$-1.26M	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	-	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-5.26M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$4.73M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.90M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$199.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$73.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-73.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-199.00K	USD	2 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	2 Qtrs
Proceeds from initial public offering	`ProceedsFromIssuanceInitialPublicOffering`	$223.69M	USD	2 Qtrs
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	-	USD	2 Qtrs
Payments of underwriting fees, net of discounts and offering costs	`PaymentsOfStockIssuanceCosts`	$12.66M	USD	2 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$438.00K	USD	2 Qtrs
Repayment of note payable	`RepaymentsOfNotesPayable`	$33.25M	USD	2 Qtrs
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	-	USD	2 Qtrs
Proceeds from exercised stock options	`ProceedsFromStockOptionsExercised`	$2.92M	USD	2 Qtrs
Proceeds from non-controlling interest	`ProceedsFromMinorityShareholders`	$125.00K	USD	2 Qtrs
Proceeds from non-controlling interest	`ProceedsFromMinorityShareholders`	-	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$210.59M	USD	2 Qtrs
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-30.21M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$215.12M	USD	2 Qtrs
Net (decrease) increase in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-28.38M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$299.75M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.58M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$292.19M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$84.63M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$299.75M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$320.58M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$292.19M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$647.00K	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$585.00K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$245.00K	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$451.00K	USD	2 Qtrs

Stockholders Equity 31 line items

Line Item	Tag	Value	Unit	Period
Beginning balance (in shares)	`CommonStockSharesOutstanding`	107.84M	shares	Point-in-time
Beginning balance (in shares)	`CommonStockSharesOutstanding`	109.58M	shares	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.90M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$467.11M	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$18.47M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$202.56M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$101.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$24.88M	USD	1 Quarter
Issuance of common stock upon closing of initial public offering	`StockIssuedDuringPeriodValueNewIssues`	$210.99M	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$2.12M	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$33.00K	USD	1 Quarter
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	`StockIssuedDuringPeriodValueShareBasedCompensation`	$799.00K	USD	1 Quarter
Contributed non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$125.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-29.47M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$5.62M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-11.38M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-173.49M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-18.09M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-167.87M	USD	2 Qtrs
Ending balance (in shares)	`CommonStockSharesOutstanding`	107.84M	shares	Point-in-time
Ending balance (in shares)	`CommonStockSharesOutstanding`	109.58M	shares	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$149.37M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$389.47M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$450.18M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$457.90M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$143.65M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$467.11M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.